ripekg:evaluation/RIPEA07C7CD7A66B0506A |
prov:used |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA07C7CD7A66B0506A |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA07C7CD7A66B0506A |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
ripe:concerns |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
ripe:recruitmentEndDate |
31-05-2017 |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
ripe:recruitmentEndDateExtractionRationale |
Participants were recruited until May 31, 2017. |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
ripe:recruitmentStartDate |
03-06-2014 |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
ripe:recruitmentStartDateExtractionRationale |
Participants were recruited from June 3, 2014. |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
ripe:studyEndDateExtractionRationale |
No explicit study end date found; only the follow-up duration (5 years) is mentioned. |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA07C7CD7A66B0506A-human-2-2 |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA07C7CD7A66B0506A-inspectai-2-2 |